Molecular Mechanisms of Kidney Disease, @StanfordNeph; Director, @Stanford_HTN; Director, @PreRenal_SU; @KidneyInCVD; @BhallaResearch@med-mastodon.com
Stanford, CA
Joined February 2020
- Tweets3.1K
- Following603
- Followers1.7K
- Likes27.3K
Laboratory of Vivek Bhalla, MD- Stanford retweeted
Come see what the Pittsburgh Center for Kidney Research can do to help your bench research - TH-INFO-11. I’m here to discuss! #kidneywk @pittkidneyctr
Laboratory of Vivek Bhalla, MD- Stanford retweeted
It was a great experience for our team to present & to hear about great research in the field. With appreciation for novel mechanisms, new diagnostics and new therapies, hypertension is having a moment, and we must all rise to meet it. The future is hopeful for #hypertension care
Laboratory of Vivek Bhalla, MD- Stanford retweeted
@HyperAHA #CPC Session at @CouncilonHTN @KidneyInCVD #Hypertension26 starting with 🌟 Faculty Panel & great initiatives❗️
🎯 case presentation Vivek @BhallaResearch from Dr Jehan Zahid Bahrainwala 👏👏
➡️ A young woman with hypokalemia & #hypertension
@LabTouyz @jenniferlcluett @DrJMLuther
Laboratory of Vivek Bhalla, MD- Stanford retweeted
1. CRISPR came from basic research on bacteria.
2. Optogenetics started with a discovery in algae.
3. The GFP protein comes from jellyfish.
The biggest breakthroughs all trace to scientists follow their curiosity. This is one huge reason why we must keep funding basic research!
Laboratory of Vivek Bhalla, MD- Stanford retweeted
D-24 until #Hypertension26 Oct 7-11 in Arlington, VA! We expect phenomenal sessions including cuffless 24hr ABPM in HTN management, SGLT2 inhibition in salt-sensitive HTN🫘↔️🫀, renal denervation for resistant HTN, GLP-1a in lowering BP, and many more! professional.heart.org/en/me…
Laboratory of Vivek Bhalla, MD- Stanford retweeted
I’m a doctor. This executive order is wrong. The President does not have the expertise to make these changes.
Vaccines are overwhelmingly safe. Vaccines are effective. Vaccines DO NOT cause autism.
Breaking up vaccines will mean children have to get more shots to get the same protection, not fewer shots. It will increase hesitancy and make children less safe.
Parents should listen to their child’s pediatrician about vaccines rather than listening to an inaccurate executive order. This is so wrong.
xitter.cf/axios/status/208688294…
Trump executive order would split up MMR vaccine axios.com/2026/08/10/trump-o…
Laboratory of Vivek Bhalla, MD- Stanford retweeted
Final call: Can you teach the kidney–heart connection better than a slide deck can?
Build it. The @AHAScience @KidneyInCVD Council is recognizing up to 3 educational tools.
Teams of students, residents, fellows & faculty may apply by Aug 7, 2026. @MLGumz
Laboratory of Vivek Bhalla, MD- Stanford retweeted
Congratulations @Tobias_B_Huber and Team this is really great news for the kidney community and our patients 🙌🙌🚀🚀❤️
HCKH-Launch-News: We officially launched the Hamburg Center for Kidney Health (HCKH) together with the leadership of the University of Hamburg (@unihh) and University Medical Center Hamburg-Eppendorf (@UKEHamburg), and distinguished international leaders from the European Renal Association (ERA) (@ERAkidney, @torra_roser), International Society of Nephrology (ISN) (@ISNkidneycare, @kidneydoc101), International Society of Glomerular Disease (ISGD) (@ISGDtweets), African Association of Nephrology (AFRAN) (@Rasha_Darwish_), NephCure Kidney International (@nephcure), Greifswald University (@uni_greifswald, @EndlichNicole) and UTMB (@utmbhealth, @JochenReiser) alongside patients, clinicians, scientists, and the next generation of kidney researchers.
HCKH is now among the world's leading academic platforms for kidney health, bringing together more than 250 kidney experts and internationally recognized programs spanning precision medicine, AI, systems biology, biobanking, integrated patient care, education, and translation.
Our ambition: to redefine kidney medicine, from understanding disease mechanisms to delivering precision therapies, and to translate scientific discovery into longer, healthier lives for people living with kidney disease.
A heartfelt thank you to our outstanding speakers, colleagues, patients, collaborators, partners in joint programs (@UniklinikAachen, @rkramann, @AarhusUni, @UKKoeln, @UK_Muenster, @Uniklinik_Fr, @SFB1453_NephGen, etc.), supporters, and the entire HCKH team for making this inaugural symposium such an inspiring milestone. This is only the beginning.
#HCKH #KidneyHealth #TeamScience #GlobalHealth #Innovation
Laboratory of Vivek Bhalla, MD- Stanford retweeted
Many congrats @KatherineTuttl8 !! The @KidneyInCVD council is so honored to have your lifetime achievements and contributions to the CKM space recognized ! @BhallaResearch @AHAScience @ASNKidney #SavingKidneysHeartsandLives @BaimInstitute
This quoted post is unavailable.
Laboratory of Vivek Bhalla, MD- Stanford retweeted
Watching Alexander Zverev compete at Roland-Garros, it is easy to see the athlete.
Diagnosed with Type 1 diabetes as a child, he is competing at the highest level of professional sport. His journey reflects decades of discoveries in insulin therapy, glucose monitoring, and diabetes care.
A reminder that biomedical research does not just change numbers in a paper. It changes lives.
For millions living with Type 1 diabetes, especially children, that matters. A quiet reminder that the disease may be part of your life, but it does not have to limit your dreams.
Laboratory of Vivek Bhalla, MD- Stanford retweeted
Hypertension (high blood pressure) is one of the most common complications of PKD. When hypertension is left untreated, it can further damage the kidneys and increase the risk of heart disease and stroke.
Learn more about managing this symptom of PKD: pkdcure.org/about-the-diseas…
Laboratory of Vivek Bhalla, MD- Stanford retweeted
This month marks 10 years of JCI Insight!
A special shoutout to authors, editors, reviewers, readers, and all those dedicated to biomedical research, ranging from preclinical to clinical studies. This video highlights selected covers through the years.
—
Music: Bensound; License code: LDOZSSOUYFKAOLR8; Artist: Theatre Of Delays
@Eickelberg_MD
Laboratory of Vivek Bhalla, MD- Stanford retweeted
Please help us bring hope and light into this Holiday Season.
One of our @StanfordNeph @StanfordAbdTxp faculty families is working to save their child’s life from a rare genetic condition.
Please read, share and support.
rarebreak.org
Laboratory of Vivek Bhalla, MD- Stanford retweeted
Congrats @StanfordMed scientists for publishing @ScienceTM showing how mRNA-based COVID vaccines can cause myocarditis via CXCL10-TNFy signaling axis.
@StanfordCVI @Stanford_ChEMH @StanfordDeptMed @stanfordimmuno @CellStanford @GreenstoneBio @brucegoldman med.stanford.edu/news/all-ne…
Laboratory of Vivek Bhalla, MD- Stanford retweeted
Thanks to Jordy and Tammy for their leadership on this important statement! @jordy_bc @TammyBradyMD
Cuffless devices estimate blood pressure (BP) indirectly. Most rely on sensors such as photoplethysmography (PPG) or tonometry, often combined with pulse transit/arrival time and machine learning. Outputs often represent BP change relative to calibration, not direct measurement.
Accuracy is particularly unclear in real-world use. Device performance is highly susceptible to motion, sensor positioning, body posture, and hydrostatic pressure effects. Yet most validation occurs immediately after calibration in static, controlled settings—leaving true real-world utility unproven.
✍🏼 @Jordy_bc @Tammybradymd @Rushellebyfield @Shakia_hardy @Spjuraschek @Deanp_bp @Roberththielemd @DrEugeneYang
Laboratory of Vivek Bhalla, MD- Stanford retweeted
We are thrilled to announce that we have generously received funding for a one-year hypertension fellowship, and we are recruiting now for a candidate to start fellowship July 1, 2026 .
med.stanford.edu/hypertensio…
-Jehan Zahid Bahrainwala
HTN Fellowship Program Director
Laboratory of Vivek Bhalla, MD- Stanford retweeted
This might be the most badass brief report I’ve read in a long time.
In @NEJM
A team just published what feels like a glimpse straight into the future of cellular therapeutics: successful survival and function of transplanted allogeneic, CRISPR-edited beta cells with zero immunosuppression — in a real human with long-standing type 1 diabetes.
No anti-rejection meds.
No immune flare.
Glucose-responsive insulin secretion documented weeks after implantation.
A clean safety profile.
This is the kind of translational science that makes you think about how close we might be to rewriting what’s possible in autoimmune and metabolic disease.
Medicine is moving fast. This is one of those papers that makes you feel it.
Laboratory of Vivek Bhalla, MD- Stanford retweeted
Game changer. ASI directed PET imaging informs the pathogenesis, diagnosis, subtyping, and treatment of primary aldosteronism, but more broadly, hypertension in general.
nejm.org/doi/full/10.1056/NE…
Laboratory of Vivek Bhalla, MD- Stanford retweeted
Some useful information about grants that were supposed to be reviewed during the shutdown.
Updated Guidance on Reopening of NIH Extramural Activities Following the October 1, 2025 - Lapse in Appropriations grants.nih.gov/grants/guide/…
Laboratory of Vivek Bhalla, MD- Stanford retweeted
Prevalence of the M1 Modifier p.N264K in APOL1 Among Individuals With Kidney Disease Undergoing Commercial Genetic Testing in the United States
bit.ly/48PB2xk (FREE)
@BhallaResearch @gchertow @DianneKeenkim @vcharuMD
